References
2015 Global Health Care Outlook. Common goals, competing priorities(2015), Deloitte Touche Tohmatsu Ltd.
Aronson, J.K. (2008), Something new every day: Defining innovation and innova-tiveness in drug therapy, Journal of Ambulatory Care Management, 31(1): 65-68.
Bariery rozwoju przedsiębiorstw, czyli co najbardziej hamuje wzrost polskich firm (2013), Raport z wyników ankiety przeprowadzonej podczas II Forum Przedsiębiorców Grant Thornton, grudzień 2013.
Bouvenot, G. (2007), The benefit provided by new medicinal products in 2005-2006 – the viewpoint of the French National Authority for health, Therapie, 62(5): 387-391.
Ciani, O., Armeni, P., Boscolo, P. R., Cavazza, M., Jommi, C., Tarricone, R. (2016), De innovatione: The concept of innovation for medical technologies and its implications for healthcare policy-making, Health Policy and Tech-nology, 5(1): 47-64.
Espacenet Patent Search (2016), available at: http://worldwide. espacenet.com/advancedSearch (accessed 07 June 2016).
Frąckowiak, J. (2016), Dane Pharma Expert dotyczące rynku farmaceutycz-nego w Polsce, available at: http://www.pharmaexpert.pl/media-files/Phar-maExpert_podsumowuje_ rynek _ farmaceutyczny marzec_2016.pdf (ac-cessed 25 April 2016).
Grajewski, B. (2015), 10 barriers to healthcare innovation, The Guardian, Healthcare Network.
Herper, M. (2013), How much does pharmaceutical innovation cost, Forbes, 11 August.
Industry Browser – Healthcare Sector – Industry List (2016), available at: https://biz.yahoo.com/p/5mktd.html (accessed 25 April 2016).Nathan, C. (2007), Aligning pharmaceutical innovation with medical need, Na-ture Medicine, 13(3): 304-308.
Nojszewska, E. (2011), Economic effectiveness as an analytical tool for health care, Management Problems, 9(3): 11-26.
OECD Health Statistics 2015 (2015), Country note: How does health spending in Poland compare?, available at: https://www.oecd.org/els/health-systems/Coun-try-Note-POLAND-OECD-Health-Statistics-2015.pdf (accessed 31 May 2016).
OECD (2015), Health at a glance 2015, OECD Indicators.
Omachonu, V.K., Einspruch, N.G. (2010), Innovation in healthcare delivery systems: A conceptual framework, The Innovation Journal: The Public Sec-tor Innovation Journal, 15(1): 1-20.
Rynek Zdrowia (2015), Wartość aptecznego rynku farmaceutycznego w IV kwartale 2015 r. wzrosła o 3,6 proc., available at: http://www.rynekzdrowia.pl/Farmacja/Wartosc-aptecznego-rynku-farmaceutycznego-w-IV-kwar-tale-2015-r-wzrosla-o-3-6-proc,158308,6.html (accessed 25 April 2016).
2007 to 2020, available at: http://www.statista.com/statistics/309297/ world-wide-medtech-research-and-development-spending/ (accessed 25 April 2016).
Webb, D.J. (2011), Value-based medicine pricing: NICE work?, Lancet, 377(9777): 1552-1553.
WIPO International Patent Classification (IPC) Official Publication, http://web2.wipo.int/classifications/ipc/ipcpub/#refresh=page (accessed 07 June 2016).
Włodarczyk, W. (2016), Rośnie rynek wyrobów medycznych, jego wartość już przekracza 2 mld dolarów, terMedia, available at: http://www.termedia.pl/mz/Rosnie-rynek-wyrobow-medycznych-jego-wartosc-juz-przekracza-2-mld-dolarow,19049.html (accessed 25 April 2016).
English
Język Polski
Deutsch
Русский
